Cargando…

Levofloxacin Induced Toxic Epidermal Necrolysis: Successful Therapy with Omalizumab (Anti-IgE) and Pulse Prednisolone

Patient: Female, 74 Final Diagnosis: Toxic epidermal necrolysis Symptoms: Bullous hemorrhagic lesions Medication: Levoflaxosine Clinical Procedure: Omalizumab therapy Specialty: Allergology OBJECTIVE: Rare disease BACKGROUND: Toxic epidermal necrolysis (TEN) is characterized by widespread erythemato...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uzun, Rusen, Yalcin, Arzu Didem, Celik, Betul, Bulut, Tangul, Yalcin, Ata Nevzat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027856/ https://www.ncbi.nlm.nih.gov/pubmed/27634312 http://dx.doi.org/10.12659/AJCR.899823

Ejemplares similares

Allergic diseases of the skin and drug allergies – 2027. Successful treatment with intravenous immunoglobulin and prednisolone pulse therapy of toxic epidemal necrolysis and Stevens-Johnson Syndrome
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Levofloxacin-Induced Toxic Epidermal Necrolysis
por: Khan, Andeebia A, et al.
Publicado: (2023)

Circulating apo 2L levels decreased in hepatitis C with the pegilated interferon-2 alpha treatment
por: Yalcin, Ata Nevzat, et al.
Publicado: (2015)

Advances in Anti-IgE Therapy
por: Yalcin, Arzu Didem
Publicado: (2015)

An Overview of the Effects of anti-IgE Therapies
por: Yalcin, Arzu Didem
Publicado: (2014)

Prednisolone: Toxic epidermal necrolysis and cytomegalovirus infections: case report
Publicado: (2021)

270 Clinical Experience in Allergic Asthma Patients: Omalizumab with Immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Omalizumab in symptomatic therapy of laryngeal oedema and urticaria attacts in a patient with post operative pulmonary carsinoid tumor
por: Yalcin, Arzu Didem, et al.
Publicado: (2015)

Clear Cell Dermatofibroma on the Chest Wall: A Case Report and Its Diagnostic Traps
por: Bulut, Tangul, et al.
Publicado: (2018)

Health outcomes, education, healthcare delivery and quality – 3038: The relation of sTRAIL levels and quality of life in omalizumab using severe persistent allergic asthma patients
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Common variable immunodeficiency syndrome with right aortic arch: a case report
por: Yalcin, Arzu Didem, et al.
Publicado: (2004)

Human(ized) monoclonal antibodies in atopic patients – state of the art
por: YALCIN, ARZU DIDEM, et al.
Publicado: (2020)

Subtyping of non-small cell lung cancer by cytology specimens: A proposal for resource-poor hospitals
por: Celik, Betul, et al.
Publicado: (2019)

Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: Its relation to omalizumab treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

277 Serum Soluble Trail Levels in Patients With Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Levofloxacin induced Stevens-Johnson syndrome/ toxic epidermal necrolysis overlap syndrome: case reports
por: Aversano, Maria Gloria, et al.
Publicado: (2014)

Circulating soluble apo 2L, soluble OX-2: a possible screening biomarker for stage-4 ovarian, endometrial CA
por: Yalcin, Arzu Didem, et al.
Publicado: (2015)

Health outcomes, education, healthcare delivery and quality – 3052. IL-17, IL-18, TGF-beta and GMCSF levels in patients with allergic asthma: Its relation to omalizumab treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Country-based report: the safety of omalizumab treatment in pregnant patients with asthma
por: GEMİCİOĞLU, Bilun, et al.
Publicado: (2021)

Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange
por: Pennington, Luke F., et al.
Publicado: (2016)

Extramedullary hematopoiesis within cystic renal cell carcinoma with oncocytic and chromophobe cell types: A case report
por: CELIK, BETUL, et al.
Publicado: (2014)

Toxic Epidermal Necrolysis
por: Khalifian, Saami, et al.
Publicado: (2014)

Toxic epidermal necrolysis
por: Hoetzenecker, Wolfram, et al.
Publicado: (2016)

Environmental and occupational respiratory diseases – 1039. Clinical course and side effects of anti-IgE monoclonal antibody in patients with severe persistent asthma
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

473 Evaluating Total Serum IgE Levels in Patients with Chronic Hepatitis B and C
por: Köse, Sükran, et al.
Publicado: (2012)

Review of Toxic Epidermal Necrolysis
por: Harris, Victoria, et al.
Publicado: (2016)

Toxic Epidermal Necrolysis and Sepsis
por: Alves, Daniela Dias, et al.
Publicado: (2016)

Inhibition of IgE and IgE/anti-IgE mediated responses in mast cells by Omalizumab
por: Kulka, M, et al.
Publicado: (2010)

Level of TNF-related apoptosis-inducing-ligand and CXCL8 correlated with 2-[18F]Fluoro-2-deoxy-D-glucose uptake in anti-VEGF treated colon cancers
por: Celik, Betül, et al.
Publicado: (2013)

Immunotherapy – 2071. Strail levels decreased after allergen-subcutaneous specific immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Efficacy of Omalizumab Therapy in an Asthmatic with Low IgE
por: R, Divya, et al.
Publicado: (2020)

Omalizumab and IgE in the Control of Severe Allergic Asthma
por: Gon, Yasuhiro, et al.
Publicado: (2022)

Omalizumab and cancer risk: Current evidence in allergic asthma, chronic urticaria, and chronic rhinosinusitis with nasal polyps
por: Bagnasco, Diego, et al.
Publicado: (2022)

278 Total Antioxidant Capacity, Hydrogen Peroxide, Malondialdehyde and Total Nitric Oxide Concentrations in Patients With Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Carbamzepine-induced toxic epidermal necrolysis
por: Chowta, Nithyananda K., et al.
Publicado: (2011)

Ofloxacin-induced toxic epidermal necrolysis
por: Gupta, Gaurang
Publicado: (2014)

Toxic epidermal necrolysis induced by lansoprazole()
por: Fracaroli, Tainá Scalfoni, et al.
Publicado: (2013)

Rapidly Developing Toxic Epidermal Necrolysis
por: Poulsen, Viktoria Oline Barrios, et al.
Publicado: (2013)

Toxic epidermal necrolysis in hemodialysis patient
por: Mateti, Uday Venkat, et al.
Publicado: (2015)

Early Manifestations of Toxic Epidermal Necrolysis
por: Chapman, James, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_09jm04d4sifuoomkkm7482e46g